Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity

ClinicalTrials.gov ID: NCT06579092

Public ClinicalTrials.gov record NCT06579092. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIb Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD5004 in Participants Living With Obesity or Overweight With Comorbidity

Study identification

NCT ID
NCT06579092
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
310 participants

Conditions and interventions

Interventions

  • AZD5004 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 7, 2024
Primary completion
Nov 20, 2025
Completion
Nov 20, 2025
Last update posted
Dec 17, 2025

2024 – 2025

United States locations

U.S. sites
30
U.S. states
19
U.S. cities
30
Facility City State ZIP Site status
Research Site Chandler Arizona 85225
Research Site Huntington Park California 90255
Research Site La Mesa California 91942
Research Site Lincoln California 95648
Research Site Walnut Creek California 94598
Research Site Hialeah Florida 33012
Research Site Orlando Florida 32806
Research Site Lombard Illinois 60148
Research Site Valparaiso Indiana 46383
Research Site West Des Moines Iowa 50266
Research Site Roslindale Massachusetts 02131
Research Site Farmington Hills Michigan 48334
Research Site Chesterfield Missouri 63005
Research Site Omaha Nebraska 68134
Research Site Vestal New York 13850
Research Site Durham North Carolina 27701
Research Site Wilmington North Carolina 28401
Research Site Fargo North Dakota 58104
Research Site Beachwood Ohio 44122
Research Site Cincinnati Ohio 45219
Research Site North Charleston South Carolina 29405
Research Site Spartanburg South Carolina 29303
Research Site Knoxville Tennessee 37912
Research Site Austin Texas 78735
Research Site Dallas Texas 75230
Research Site Houston Texas 77040
Research Site Woodway Texas 76712
Research Site Ogden Utah 84405
Research Site Charlottesville Virginia 22911
Research Site Manassas Virginia 20110

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06579092, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 17, 2025 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06579092 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →